See the Glossary for more terms.
NIAID welcomes our new Council members for 2015: Amanda Castel, Stephen J. Galli, John Guatelli, and Gurjit Khurana Hershey.
Adaora Adimora, M.D., M.P.H., is professor of medicine and epidemiology at the University of North Carolina at Chapel Hill. She is a physician-epidemiologist with specialty training and extensive clinical experience in infectious diseases with a focus on HIV. Her research has characterized the epidemiology of heterosexual HIV transmission among African Americans, highlighted the role of sexual network patterns in the spread of HIV, and underscored the importance of macroeconomic and social forces in racial disparities in the U.S. HIV epidemic. Dr. Adimora serves as chair of the NIH HIV Prevention Trials Network Women at Risk Committee and is a member of the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents. (October 31, 2015)
Amanda Castel, M.D., M.P.H., is associate professor of epidemiology and pediatrics at The George Washington University. She is a medical epidemiologist with training in preventive medicine and applied public health epidemiology. One of Dr. Castel’s research areas is characterizing outcomes along the HIV-care continuum through the use of public health surveillance and clinical data. She also develops interventions to maximize outcomes along the continuum, including routine testing expansion, enhancing retention in care and medication adherence, and reducing community viral load. (October 31, 2018)
Georgia D. Tomaras, Ph.D., is associate professor of surgery, immunology, and molecular genetics and microbiology at Duke University Medical Center as well as a faculty member of its Center for Virology and the Computational Biology and Bioinformatics Program. She is also associate director of research and director of the Training and Mentoring Program at the Duke Human Vaccine Institute. The goal of her research program is to understand the cellular and humoral immune responses to HIV-1 infection and vaccination that are involved in protection from HIV-1. Her laboratory focuses on the induction and ontogeny of systemic and mucosal antibody responses and antiviral CD8+ T cell responses. (October 31, 2015)
Stephen J. Galli, M.D., is Mary Hewitt Loveless, M.D., Professor; chair and professor of pathology; and professor of microbiology and immunology at Stanford University. He investigates the roles of mast cells and basophils in health and disease, including in host defense and allergic disorders such as food allergy and asthma. Dr. Galli has been a member or chair of NIH study sections and co-chaired an NIAID Food Allergy Research Expert Panel. He belongs to the Collegium Internationale Allergologicum where he served as president from 2010 to 2014, Institute of Medicine of the U.S. National Academy of Sciences, and Accademia Nazionale dei Lincei. (October 31, 2018)
Gurjit Khurana Hershey, M.D., Ph.D., is endowed professor of pediatrics at Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, and director of the Division of Asthma Research. She is also director of the Medical Scientist Training Program at the University of Cincinnati and co-director of the Office of Pediatric Clinical Fellowships at Cincinnati Children's Hospital Medical Center. Dr. Khurana Hershey’s research focuses on the overall goal of improving the health of children with asthma. Her laboratory integrates clinical, epidemiologic, translational, and basic research approaches to identify and delineate the mechanistic basis of genetic and environmental factors that contribute to the development, progression, and persistence of asthma. (October 31, 2018)
Arlene Sharpe, M.D., Ph.D., is George Fabyan Professor of Comparative Pathology at Harvard Medical School. She is also head of the Division of Immunology in the Department of Microbiology and Immunobiology and co-director of the Harvard Institute of Translational lmmunology. Dr. Sharpe is a leader in the field of costimulation. Her laboratory currently focuses on the roles of T cell costimulatory pathways in regulating pathogenic and protective immune responses needed for inducing and maintaining T cell tolerance and effective antimicrobial and antitumor immunity. Her laboratory is also involved in studies aimed at translating fundamental understanding of T cell costimulation into new therapies for autoimmune diseases, chronic viral infections, and tumor immunotherapy. (October 31, 2017)
Mavis Agbandje-McKenna, Ph.D., is professor in the Department of Biochemistry and Molecular Biology and director of the Center for Structural Biology in the College of Medicine at the University of Florida. Her laboratory uses structural biology and biophysical tools combined with biochemistry and molecular biology to study single-stranded DNA viruses. The goal of her research is to obtain a fundamental understanding of the virus and host determinants of tissue tropism, host adaptation, host pathogenicity, and virus-host immune system interactions. (October 31, 2015)
Norman W. Baylor, Ph.D., is president and CEO of Biologics Consulting Group, Inc. Previously, Dr. Baylor was the director of the Office of Vaccines Research and Review in the Food and Drug Administration’s Center for Biologics Evaluation and Research. He evaluated and facilitated the development and licensure of numerous vaccines. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, U.S. Department of Health and Human Services National Vaccine Advisory Committee, and the Advisory Commission on Childhood Vaccines. He also served as an expert advisor to the World Health Organization on several global vaccine initiatives. (October 31, 2016)
Larry S. Schlesinger, M.D., is Samuel Saslaw Professor and chair of the Department of Microbial Infection and Immunity in the College of Medicine at The Ohio State University. He also serves as director of the OSU Center for Microbial Interface Biology and Medical Scientist Training Program. Dr. Schlesinger is a cellular immunologist whose studies focus on the pathogenesis of tuberculosis and other airborne infections caused by intracellular pathogens that subvert lung immune mechanisms. He has been a member or chair of several study sections at NIH and other federal and private agencies. (October 31, 2017)
For more information, see the Advisory Council portal.
Last Updated January 23, 2015
Last Reviewed January 23, 2015